Guardant Health
GH
NASDAQ
IPO2018
about GH
Guardant Health offers a non-invasive blood test for early cancer detection and monitoring.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $72.56 | $73.31 | $70.01 | $9.00B | 1.97M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.80 | n/a | 38.57 | -45.85% | -43.04% | 0% |